09 Jun 2021
NetTargets has partnered with Cellkey, which provides a cutting-edge AI-based glycopeptide analysis platform, to discover biomarkers for early detection and treatment of cancer.
NetTargets has partnered with Daewoong Therapeutics, for an anticancer drug research collaboration using NetTargets N-Map and N-Cap which are "AI-enhanced systems biology" based drug development platforms.
04 May 2022
The Korea Economic Daily introduced NetTargets Inc. as a rising AI startup, featuring its technology as the golden-egg goose.
02 Dec 2021
Korea AI Startup 100 is a project to discover next-generation unicorn companies in the field of artificial intelligence (AI).
25 Oct 2021
Our next news and events are coming soon